Latest return on equity
Regeneron Pharmaceuticals Return on equity
Direct answer
Regeneron Pharmaceuticals's return on equity is 14.04%.
The verified market snapshot reports 14.04%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 14.04%
Explore related company data
View Regeneron Pharmaceuticals's market capitalizationView Regeneron Pharmaceuticals's p/e ratioView Regeneron Pharmaceuticals's price-to-book ratioView Regeneron Pharmaceuticals's dividend yieldView Regeneron Pharmaceuticals's 52-week price rangeView Regeneron Pharmaceuticals's revenue growthView Regeneron Pharmaceuticals's profit marginView Regeneron Pharmaceuticals's debt-to-equity ratioView all Regeneron Pharmaceuticals key metricsReturn to Regeneron Pharmaceuticals profile